FilingSEC EDGAR8-K
Standard BioTools Changes Buyer for Mass Cytometry Business
· SEC accepted
StageAgreement Signed
Filing content
Standard BioTools terminated its previous sale agreement and entered into a new $5.5 million definitive agreement to sell its Mass Cytometry business to Element Biosystems.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…